D. Jewell

T. Ahmad, D. Jewell, S. Marshall, 2004, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Characterization of Inflammatory Bowel Disease With Urinary Metabolic Profiling

D. Jewell, S. Taylor-Robinson, S. Marshall, 2009, The American Journal of Gastroenterology.

The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link

D. Jewell, B. Warren, N. Mortensen, 2000, The Journal of pathology.

Use of complete eluted peptide sequence data from HLA-DR and -DQ molecules to predict T cell epitopes, and the influence of the nonbinding terminal regions of ligands in epitope selection.

D. Jewell, A. Hill, M. Davenport, 1998, Journal of immunology.

CELL-MEDIATED IMMUNITY TO A SYNTHETIC GLIADIN PEPTIDE RESEMBLING A SEQUENCE FROM ADENOVIRUS 12

D. Jewell, J. Priddle, J. Karagiannis, 1987, The Lancet.

In vivo toxicity of a synthetic dodecapeptide from A gliadin in patients with coeliac disease.

D. Jewell, G. Mantzaris, 1991, Scandinavian journal of gastroenterology.

Intensive intravenous regimen for severe attacks of ulcerative colitis.

D. Jewell, S. Truelove, 1974, Lancet.

Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis.

D. Jewell, R. Chapman, W. Selby, 1986, Gut.

Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease.

D. Jewell, W. Cookson, D. McGovern, 2005, Human molecular genetics.

PTU-029 Managing the long-term care of inflammatory bowel disease patients: the cost to European health care providers

D. Jewell, S. Wordsworth, J. Buchanan, 2010, Gut.

Cyclosporine for induction of remission in Crohn's disease.

D. Jewell, B. Feagan, J. Macdonald, 2005, The Cochrane database of systematic reviews.

The function in vitro of macrophages from the intestinal mucosa of patients with Crohn's disease: An association between chemotactic migration and granulomata

C. H. Mason, D. Jewell, P. Gibson, 1988 .

D. Jewell, P. Gibson, A. Hermanowicz, 1987, Gut.

D. Jewell, P. Gibson, A. Hermanowicz, 1987 .

Adhesion molecule expression on vascular endothelium and nitroblue tetrazolium reducing activity in human colonic mucosa.

D. Jewell, N. Oshitani, K. Kobayashi, 1995, Scandinavian journal of gastroenterology.

Optimizing Outcomes in Hepatitis C: Is Treatment Beyond 48 Weeks Ever Justified?

Kalden, D. Jewell, P. Lipsky, 2006 .

Salicylates for ulcerative colitis--their mode of action.

D. Jewell, S. Travis, Derek P. Jewell, 1994, Pharmacology & therapeutics.

Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history

D. Jewell, Bryan Paul Wordsworth, T. Orchard, 1998, Gut.

Oral methotrexate in ulcerative colitis

D. Jewell, S. Travis, K. Herrlinger, 2005, Alimentary pharmacology & therapeutics.

Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease

Clive M. Onnie, C. Mathew, D. Jewell, 2005, The Lancet.

The role of platelet-activating factor in the pathogenesis of gastrointestinal disease.

D. Jewell, S. Travis, Derek P. Jewell, 1994, Prostaglandins, leukotrienes, and essential fatty acids.

Salicylates for inflammatory bowel disease.

D. Jewell, S. Travis, 1994, Bailliere's clinical gastroenterology.

Mechanisms of diarrhea in ulcerative colitis.

D. Jewell, S. Travis, 1993, Gastroenterology.

High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility.

T. Ahmad, D. Jewell, M. Barnardo, 2002, Tissue antigens.

Immunohistologic demonstration of abnormal colonic crypt cell kinetics in ulcerative colitis.

D. Jewell, D. Mason, K. Gatter, 1985, Human pathology.

Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation.

D. Jewell, S. Gordon, M. Cappello, 1992, Gut.

Changing pattern of gastric cancer in Oxfordshire.

D. Jewell, N. Shepherd, F. Sitas, 1992, Gut.

Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: time for a reappraisal?

D. Jewell, A. Thillainayagam, G. M. Hyde, 1998, European journal of gastroenterology & hepatology.

Fistulating Anal Crohn’s Disease: Results of Combined Surgical and Infliximab Treatment

D. Jewell, S. Travis, B. George, 2006, Diseases of the colon and rectum.

The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release.

D. Jewell, A. Leslie, O. Harrison, 2013, Immunity.

The pathogenesis of celiac disease.

D. Jewell, A. Godkin, 1998, Gastroenterology.

Colorectal cancer inulcerative colitis: acohort study of primary referrals fromthree centres

D. Jewell, R. Löfberg, S. Gyde, 1988 .

Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility

D. Jewell, C. Mullighan, K. Welsh, 2000, Gut.

Immunohistological characterisation of intraepithelial lymphocytes of the human gastrointestinal tract.

D. Jewell, W. Selby, G. Janossy, 1981, Gut.

The IBD6 Crohn's disease locus demonstrates complex interactions with CARD15 and IBD5 disease-associated variants.

L. Cardon, D. Jewell, D. McGovern, 2003, Human molecular genetics.

Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis.

T. Ahmad, D. Jewell, D. McGovern, 2003, American journal of human genetics.

Prevalence of CARD15/NOD2 Mutations in Caucasian Healthy People

Judy H. Cho, J. Rioux, M. Parkes, 2007, The American Journal of Gastroenterology.

Analysis of the IBD5 locus and potential gene-gene interactions in Crohn’s disease

L. Cardon, D. Jewell, D. McGovern, 2003, Gut.

Single nucleotide polymorphisms in TNFSF 15 confer susceptibility to Crohn ’ s disease

J. Ragoussis, L. Cardon, D. Jewell, 2005 .

Confirmation of the novel association at the BTNL2 locus with ulcerative colitis.

J. Barrett, D. Jewell, A. Morris, 2009, Tissue antigens.

Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility

T. Ahmad, D. Jewell, J. Trowsdale, 2006, Genes and Immunity.

Immune complexes in acute and chronic liver disease.

D. Jewell, S. Sherlock, H. Thomas, 1978, Clinical and experimental immunology.

Role of the faecal stream in the maintenance of Crohn's colitis.

D. Jewell, M. Bennett, M. Kettlewell, 1985, Gut.

Liver and biliary Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis

D. Jewell, R. Chapman, A. Heryet, 2006 .

Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of colon.

D. Jewell, G. McDonald, 1987, Journal of clinical pathology.

Cellular hypersensitivity to gluten derived peptides in coeliac disease.

D. Jewell, J. Priddle, R. Guan, 1987, Gut.

SPLENIC PHAGOCYTIC FUNCTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

D. Jewell, J. Pettit, J. Berney, 1981, Pathology.

T lymphocyte subsets in human intestinal mucosa: the distribution and relationship to MHC-derived antigens.

D. Jewell, W. Selby, G. Janossy, 1981, Clinical and experimental immunology.

The immunology of coeliac disease

D. Jewell, G. Mantzaris, W. Rosenberg, 2004, Springer Seminars in Immunopathology.

Lymphocyte subpopulations in the human small intestine. The findings in normal mucosa and in the mucosa of patients with adult coeliac disease.

D. Jewell, W. Selby, G. Janossy, 1983, Clinical and experimental immunology.

Circulating immune complexes in ulcerative colitis and Crohn's disease.

D. Jewell, I. Maclennan, S. Truelove, 1972, Gut.

Circulating antibodies to cow's milk proteins in ulcerative colitis

D. Jewell, S. Truelove, 1972, Gut.

Natural killer cells and spontaneous cell-mediated cytotoxicity in the human intestine.

D. Jewell, W. Selby, P. Gibson, 1984, Clinical and experimental immunology.

Lymphocyte and macrophage subpopulations in pelvic ileal pouches.

D. Jewell, H. J. de Silva, N. Mortensen, 1991, Gut.

Specific IgG subclass antibodies, IgE and IgG S‐TS antibodies to wheat gluten fraction B in patients with coeliac disease

D. Jewell, D. Jewell, J. Faux, 1985, Clinical allergy.

Reaginic hypersensitivity in ulcerative colitis

D. Jewell, S. Truelove, 1972, Gut.

Altered expression of mucins throughout the colon in ulcerative colitis.

D. Jewell, J. Milton, R. Pigott, 1997, Gut.

Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn’s disease

A. Forbes, C. Mathew, D. Jewell, 2005, Gut.

Human keratin 8 mutations that disturb filament assembly observed in inflammatory bowel disease patients

M. Parkes, J. Satsangi, D. Jewell, 2004, Journal of Cell Science.

Crohn's disease: genetic susceptibility, bacteria, and innate immunity

D. Jewell, D. McGovern, D. Heel, 2001, The Lancet.

Subcellular localisation of vitamin B12 during absorption in the guinea-pig ileum.

D. Jewell, W. Jenkins, R. Empson, 1981, Gut.

Review article: Pathophysiology of the intestinal mucosa in inflammatory bowel disease and arthritis: similarities and dissimilarities in clinical findings

D. Jewell, T. Orchard, 1997, Alimentary pharmacology & therapeutics.

Split ileostomy and ileocolostomy for Crohn's disease of the colon and ulcerative colitis: a 20 year survey.

D. Jewell, S. Truelove, M. Kettlewell, 1983, Gut.

Factors inducing relapse in inflammatory bowel disease.

D. Jewell, A. Mee, 1978, British medical journal.

Chronic immune colitis in rabbits.

D. Jewell, A. Mee, H. Hodgson, 1979, Gut.

Functional and biochemical subtypes of the haplotype HLA-DR3 in patients with celiac disease or idiopathic membranous nephropathy.

D. Jewell, A. McMichael, K. Wood, 1987, Human immunology.

Alpha 1-antitrypsin serum concentration and phenotypes in ulcerative colitis.

D. Jewell, W. Selby, E. Klasen, 1984, Digestion.

Coeliac disease in primary care: case finding study

D. Jewell, H. Hin, G. Bird, 1999, BMJ.

Pelvic and perineal complications of Crohn's disease: assessment using magnetic resonance imaging.

D. Jewell, S. Travis, J. Shearman, 1995, Gut.

IFN gamma and CXCR-1 gene polymorphisms in idiopathic bronchiectasis.

D. Jewell, D. Altmann, R. Boyton, 2006, Tissue antigens.

Emergence of inflammatory bowel disease 'beyond the West': do prosperity and improved hygiene have a role?

D. Jewell, H. J. de Silva, N. D. de Silva, 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease

D. Jewell, A. Hill, D. V. van Heel, 2005, Gut.

Pharmacotherapy for inducing and maintaining remission in pouchitis.

D. Jewell, R. McLeod, W. Sandborn, 1998, The Cochrane database of systematic reviews.

Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group.

D. Jewell, P. Rutgeerts, P. Rutgeerts, 1999, Gastroenterology.

Cytokine gene polymorphisms in inflammatory bowel disease.

M. Parkes, J. Satsangi, D. Jewell, 1996, Gut.

Monocytes in inflammatory bowel disease: monocyte and serum lysosomal enzyme activity.

D. Jewell, A. Mee, Derek P. Jewell, 1980, Clinical science.

The immunology of inflammatory bowel disease

D. Jewell, J. Lowes, 1990, Springer Seminars in Immunopathology.

Two-color immunofluorescence and flow cytometric analysis of peripheral blood lymphocyte subsets in Caucasian and Japanese healthy subjects.

D. Jewell, F. Hulstaert, K. Makiyama, 1991, Japanese journal of medicine.

Salicylates used in inflammatory bowel disease and colchicine impair interferon-gamma induced HLA-DR expression.

D. Jewell, H. Dalton, B. Crotty, 1992, Gut.

Clq metabolism in ulcerative colitis and Crohn's disease.

D. Jewell, A. Mee, H. Hodgson, 1979, Gut.

Characterisation and quantification of mucosal cytokine that induces epithelial histocompatibility locus antigen-DR expression in inflammatory bowel disease.

D. Jewell, J. Priddle, P. Radwan, 1992, Gut.

The immunology of inflammatory bowel disease.

D. Jewell, J. Lowes, 1990, Springer seminars in immunopathology.

FUTURE DIRECTIONS FOR IMMUNOLOGICAL RESEARCH

D. Jewell, 1986 .

Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.

D. Jewell, W. Selby, D. Mason, 1983, Clinical and experimental immunology.

Motility of neutrophils and monocytes in Crohn's disease and ulcerative colitis.

D. Jewell, J. Rhodes, 1983, Gut.

Monocytes in inflammatory bowel disease: absolute monocyte counts.

D. Jewell, A. Mee, J. Berney, 1980, Journal of clinical pathology.

The preparation of human intrinsic factor-cobalamin complex from human gastric juice by immunoadsorption.

D. Jewell, J. Priddle, H. Shepherd, 1984, Clinica chimica acta; international journal of clinical chemistry.

Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques.

D. Jewell, W. Selby, G. Janossy, 1984, Gut.

The effect of interleukin-10 and transforming growth factor beta-1 on HLA-DR expression in colonic epithelial cells.

D. Jewell, G. Radford-Smith, M. Zimmerman, 1998, Mediators of inflammation.

10 Cytokines and inflammatory bowel disease

D. Jewell, G. Radford-Smith, 1996 .

Local immune mechanisms in inflammatory bowel disease and colorectal carcinoma

D. Jewell, P. Gibson, 1986 .

Local immune mechanisms in inflammatory bowel disease and colorectal carcinoma. Natural killer cells and their activity.

D. Jewell, P. Gibson, 1986, Gastroenterology.

Isolation of intestinal mononuclear cells: factors released which affect lymphocyte viability and function.

D. Jewell, P. Gibson, H. Verhaar, 1984, Gut.

Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting

D. Jewell, H. J. de Silva, A. Manamperi, 2012, Scandinavian journal of gastroenterology.

Small bowel gas in severe ulcerative colitis.

D. Jewell, D. Nolan, D. Jewell, 1991, Gut.

Clinical and functional outcome after restorative proctocolectomy

D. Jewell, H. J. de Silva, N. Mortensen, 1991, The British journal of surgery.

High‐Dose Methylprednisolone in the Treatment of Active Ulcerative Colitis

D. Jewell, A. Ireland, W. Rosenberg, 1988, Journal of clinical gastroenterology.

Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease.

D. Jewell, F. Hulstaert, J. Lowder, 1991, Gut.

T lymphocyte subsets in inflammatory bowel disease: peripheral blood.

D. Jewell, W. Selby, 1983, Gut.

Cytokine gene expression in HIV‐infected intestinal mucosa

D. Jewell, I. McGowan, G. Radford-Smith, 1994, AIDS.

A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.

D. Jewell, M. Vatn, F. T. Veloso, 1998, The New England journal of medicine.

T cells in peripheral blood after gluten challenge in coeliac disease

D. Jewell, A. Hill, D. Heel, 2005, Gut.

TAP1 and TAP2 polymorphism in coeliac disease

D. Jewell, J. Trowsdale, J. Bell, 2004, Immunogenetics.

chronic renal failure . Gastric function and histology in

D. Jewell, J. Moorhead, M. Lewin, 2005 .

Gastric function and histology in chronic renal failure.

D. Jewell, J. Moorhead, M. Lewin, 1979, Journal of clinical pathology.

Benign intracranial hypertension and ulcerative colitis

D. Jewell, S. Truelove, 1972, The American journal of digestive diseases.

New patients, new lessons, new thinking in inflammatory bowel disease: World Congress of Gastroenterology Symposium, Montreal, Canada, September 2005

D. Jewell, 2006, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

The prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease

J. Satsangi, D. Jewell, W. Rosenberg, 1994 .

Infliximab use in Crohn's disease: impact on health care resources in the UK

H. Drummond, J. Satsangi, A. Forbes, 2005, European journal of gastroenterology & hepatology.

Ciclosporin use in acute ulcerative colitis: a long-term experience

D. Jewell, S. Travis, S. Campbell, 2005, European journal of gastroenterology & hepatology.

Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications

D. Jewell, N. Mortensen, D. Jewell, 2001, Diseases of the colon and rectum.

Optimum dose of olsalazine for maintaining remission in ulcerative colitis.

D. Jewell, S. Travis, G. Järnerot, 1994, Gut.

HETEROGENEOUS EXPRESSION OF CARCINOEMBRYONIC ANTIGEN IN THE NORMAL COLON AND UPREGULATION IN ACTIVE ULCERATIVE COLITIS

D. Jewell, B. Warren, J. Smithson, 1996, The Journal of pathology.

Use of an intravenous steroid regimen in the treatment of acute Crohn's disease.

D. Jewell, H. Shepherd, G. Barr, 1986, Journal of clinical gastroenterology.

Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study

D. Jewell, R. Chapman, K. Fleming, 2002, Gut.

Management of acute severe colitis.

D. Jewell, P. Dunckley, 2003, Best practice & research. Clinical gastroenterology.

4 Immunology of inflammatory bowel disease

D. Jewell, H. Hodgson, 1987 .

Erratum: Characterization of Inflammatory Bowel Disease With Urinary Metabolic Profiling

Subrata Ghosh, D. Jewell, S. Taylor-Robinson, 2009, The American Journal of Gastroenterology.

A comparison of budesonide with prednisolone for active Crohn's disease.

D. Jewell, P. Rutgeerts, P. Rutgeerts, 1994, The New England journal of medicine.

Oral cyclosporin for chronic active Crohn's disease: a multicentre controlled trial

D. Jewell, J. Lennard-jones, J. Lennard-Jones, 1994 .

Autoimmune and inflammatory diseases of the gastrointestinal tract

D. Jewell, H. Hodgson, 1976 .

Azathioprine in ulcerative colitis.

D. Jewell, S. Truelove, 1972, Gut.

Long‐term outcome after admission for acute severe ulcerative colitis in Oxford: The 1992–1993 cohort

D. Jewell, S. Travis, Z. Radojicic, 2009, Inflammatory bowel diseases.

Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies.

J. Satsangi, D. Jewell, K. Welsh, 2000, Genes and immunity.

A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis.

D. Jewell, V. Mani, C. Record, 1996, Gut.

The nature of the natural killer (NK) cell of human intestinal mucosa and mesenteric lymph node.

D. Jewell, P. Gibson, 1985, Clinical and experimental immunology.

The mononuclear cells of human mesenteric blood, intestinal mucosa and mesenteric lymph nodes: compartmentalization of NK cells.

D. Jewell, W. Selby, P. Gibson, 1984, Clinical and experimental immunology.

Immunology of the Colon

D. Jewell, W. Selby, 1983 .

The role of phagocytes in inflammatory bowel disease.

D. Jewell, P. Gibson, A. Hermanowicz, 1985, Clinical science.

Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study

D. Jewell, C. O'Morain, M. Kamm, 2001, Gut.

Cyclosporin A retention enemas in refractory distal ulcerative colitis and 'pouchitis'.

D. Jewell, H. Dalton, T. Winter, 1993, Scandinavian journal of gastroenterology.

Ulcerative colitis and HLA phenotype.

D. Jewell, M. Bunce, M. Cottone, 1985, Gut.

Inhibition of leucocyte motility and prevention of immune-complex experimental colitis by hydroxychloroquine.

D. Jewell, J. Rhodes, J. Mclaughlin, 1982, Gut.

Inhibition of leucocyte motility by drugs used in ulcerative colitis.

D. Jewell, J. Rhodes, T. Bartholomew, 1981, Gut.

Monocytes in inflammatory bowel disease: phagocytosis and intracellular killing.

D. Jewell, A. Mee, M. Szawatakowski, 1980, Journal of clinical pathology.

Studies on monocytes in inflammatory bowel disease: factors influencing monocyte lysosomal enzyme activity.

D. Jewell, A. Mee, B. Potter, 1980, Clinical and experimental immunology.

The Presence of Anti‐Neutrophil Antibodies Reflects Clinical and Genetic Heterogeneity Within Inflammatory Bowel Disease

J. Satsangi, D. Jewell, S. Targan, 1998, Inflammatory bowel diseases.

Gastrointestinal amyloidosis complicating psoriatic arthropathy

D. Jewell, M. Bennett, C. P. Willoughby, 1981, Postgraduate medical journal.

Advances in mucosal immunology.

D. Jewell, I. McGowan, G. R. Smith, 1997, Gastroenterology clinics of North America.

Drug therapy of ulcerative colitis.

D. Jewell, B. Crotty, Derek P. Jewell, 1992, British journal of clinical pharmacology.

Olsalazine in active ulcerative colitis.

C. H. Mason, D. Jewell, W. Selby, 1985, British medical journal.

IN SITU COMPARISON OF PHENOTYPICAL AND FUNCTIONAL ACTIVITY OF INFILTRATING CELLS IN ULCERATIVE COLITIS MUCOSA

D. Jewell, N. Oshitani, A. Campbell, 1996, The Journal of pathology.

A locus telomeric toHLA-DPB encodes susceptibility to coeliac disease

D. Jewell, J. Bell, W. Rosenberg, 2006, Immunogenetics.

Effect of human intestinal macrophages on immunoglobulin production by human intestinal mononuclear cells isolated from patients with inflammatory bowel disease

D. Jewell, J. Priddle, Y. Mahida, 1990, Clinical and experimental immunology.

The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth.

D. Jewell, J. Rhodes, P. Middleton, 1979, Scandinavian journal of gastroenterology.

Coexpression of CD4 and CD8 on peripheral blood T cells and lamina propria T cells in inflammatory bowel disease by two colour immunofluorescence and flow cytometric analysis.

D. Jewell, Y. Mahida, K. Wu, 1991, Gut.

White Cell Motility and its Inhibition by Serum Factors and Drugs

D. Jewell, J. Rhodes, 1981 .

A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease.

D. Jewell, R. Modigliani, J. Wright, 1995 .

A Randomized, Double‐Blind, Placebo‐Controlled Trial of Olsalazine for Active Crohn's Disease

D. Jewell, R. Modigliani, J. Wright, 1995, Inflammatory bowel diseases.

Sulphasalazine and derivatives, natural killer activity and ulcerative colitis.

D. Jewell, P. Gibson, 1985, Clinical science.

Effects of the faecal stream and stasis on the ileal pouch mucosa.

D. Jewell, P. Millard, H. J. de Silva, 1991, Gut.

Mucosal characteristics of pelvic ileal pouches.

D. Jewell, P. Millard, H. J. de Silva, 1991, Gut.

Production of epithelial cell growth factors by lamina propria mononuclear cells.

D. Jewell, J. Priddle, J. Lowes, 1992, Gut.

Clinical trial Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis

D. Jewell, A. Ireland, C. Mason, 2006 .

Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis.

C. H. Mason, D. Jewell, A. Ireland, 1988, Scandinavian journal of gastroenterology. Supplement.

Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis.

C. H. Mason, D. Jewell, A. Ireland, 1988, Gut.

Oral fluticasone propionate in active distal ulcerative colitis.

D. Jewell, J. Snook, P. Angus, 1992, Gut.

Long‐term follow‐up of strictureplasty for Crohn's disease

D. Jewell, B. George, N. Fearnhead, 2006, The British journal of surgery.

Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.

D. Jewell, P. Rutgeerts, Å. Danielsson, 1996, Gut.

Alpha 2-macroglobulin in patients with inflammatory bowel disease.

D. Jewell, G. Copeland, J. Khan, 1980, Journal of clinical & laboratory immunology.

Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life.

D. Jewell, M. Vatn, F. T. Veloso, 2002 .

Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life

D. Jewell, M. Vatn, F. T. Veloso, 2002, American Journal of Gastroenterology.

Studies on the acetylating capacity of human colonic epithelial cells for 5-aminosalicylic acid.

D. Jewell, J. Priddle, A. Ireland, 1988, Scandinavian journal of gastroenterology. Supplement.

Variation in the CTLA4/CD28 gene region confers an increased risk of coeliac disease.

D. Jewell, G. Holmes, J. Walters, 2002, Annals of human genetics.

Immune activation during cerebellar dysfunction following Plasmodium falciparum malaria.

D. Jewell, H. Dalton, N. D. de Silva, 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

The efficacy of methotrexate for maintaining remission in inflammatory bowel disease

D. Jewell, S. Travis, D. McGovern, 2002, Alimentary pharmacology & therapeutics.

Medical management of severe ulcerative colitis

D. Jewell, 1988, International Journal of Colorectal Disease.

Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease.

D. Jewell, B. Potter, D. Brown, 1980, Gut.

Humoral immune system in inflammatory bowel disease: I. Complement levels.

D. Jewell, H. Hodgson, B. Potter, 1977, Gut.

Acetylation of 5-aminosalicylic acid by isolated human colonic epithelial cells.

D. Jewell, J. Priddle, A. Ireland, 1990, Clinical science.

Natural killer cells andspontaneous cell-mediated cytotoxicity inthehumanintestine

D. Jewell, G. Strickland, W. Selby, 1984 .

Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes.

D. Jewell, K. Welsh, Tariq Ahmad, 2002, Gastroenterology.

Circulating immune complexes in inflammatory bowel disease.

D. Jewell, I. Maclennan, 1973, Clinical and experimental immunology.

Macrophage activity in inflammatory bowel disease.

D. Jewell, Y. Mahida, 1990, Gut.

Comprehensive, Quantitative Mapping of T Cell Epitopes in Gluten in Celiac Disease

D. Jewell, A. Hill, T. Beißbarth, 2010, Science Translational Medicine.

In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope

D. Jewell, A. Hill, A. Godkin, 2000, Nature Medicine.

Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis.

D. Jewell, P. Hersey, I. Maclennan, 1976, Clinical and experimental immunology.

Alpha-chain disease diagnosed by rectal biopsy.

D. Jewell, G. Janossy, J. Rhodes, 1980, British medical journal.

Therapy Insight: pyoderma gangrenosum—old disease, new management

D. Jewell, S. Cripps, S. Campbell, 2005, Nature Clinical Practice Gastroenterology &Hepatology.

MRI scanning in perianal Crohn's disease: an important diagnostic adjunct.

D. Jewell, N. Mortensen, N. Borley, 1999, Inflammatory bowel diseases.

MRI scanning in perianal Crohn's disease: an important diagnostic adjunct.

D. Jewell, N. Mortensen, N. Borley, 1999, Inflammatory bowel diseases.

Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.

D. Jewell, R. Chapman, S. Sherlock, 1986, Gut.

Immune-complex mediated colitis in rabbits. An experimental model.

D. Jewell, H. Hodgson, B. Potter, 1978, Gut.

Histological changes associated with the use of intravenous cyclosporin in the treatment of severe ulcerative colitis may mimic dysplasia

D. Jewell, B. Warren, D. Jewell, 2002, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

A Simple Classification of Crohn's Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998

D. Jewell, S. Hanauer, G. D'Haens, 2000, Inflammatory bowel diseases.

Isolation of parietal cells from guinea-pig gastric mucosa and the immunological characterization of their antigenic structure.

D. Jewell, K. Taylor, J. Wright, 1975, Gut.

Transient, selective factor X deficiency and acute liver failure following chest infection treated with erythromycin BP.

D. Jewell, J. Hosker, 1983, Postgraduate medical journal.

Food intolerance and the irritable bowel syndrome.

D. Jewell, R. Nanda, R. James, 1989, Gut.

Mononuclear phagocyte system of human Peyer's patches: an immunohistochemical study using monoclonal antibodies.

D. Jewell, Y. Mahida, S. Patel, 1989, Clinical and experimental immunology.

Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease.

D. Jewell, K. Welsh, Bryan Paul Wordsworth, 2000, Gastroenterology.

Expression of colonic antigens by goblet and columnar epithelial cells in ileal pouch mucosa: their association with inflammatory change and faecal stasis.

D. Jewell, N. Mortensen, N. Mortensen, 1994, Journal of clinical pathology.

Connective tissue changes in Ileal crohn's disease: Relationship to disease phenotype and ulcer-associated cell lineage

D. Jewell, B. Warren, B. George, 2001, Diseases of the colon and rectum.

NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population

D. Jewell, J. Sung, Tariq Ahmad, 2003, Alimentary pharmacology & therapeutics.

Functional consequences of mutations in the autophagy genes in the pathogenesis of Crohn's disease

D. Jewell, A. Simmons, O. Brain, 2012, Inflammatory bowel diseases.

Association of a Functional Variant in the Wnt Co-Receptor LRP6 with Early Onset Ileal Crohn's Disease

D. Jewell, P. Rutgeerts, S. Vermeire, 2012, PLoS genetics.

The Genetic Basis of Inflammatory Bowel Disease

D. Jewell, R. Cooney, 2009, Digestive Diseases.

Genetic Variants of Wnt Transcription Factor TCF-4 (TCF7L2) Putative Promoter Region Are Associated with Small Intestinal Crohn's Disease

D. Jewell, P. Rutgeerts, S. Vermeire, 2009, PloS one.

NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation

D. Jewell, D. Ferguson, A. Simmons, 2010, Nature Medicine.

Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12

J. Terwilliger, M. Parkes, J. Satsangi, 1996, Nature Genetics.

Review article: the genetics of inflammatory bowel disease.

J. Satsangi, D. Jewell, M. Bunce, 2001, Alimentary pharmacology & therapeutics.

Genetics of inflammatory bowel disease.

J. Satsangi, T. Ahmad, D. Jewell, 1994, Gut.

Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum.

D. Jewell, D. Vaux, P. Gionchetti, 1989, Gut.

Interleukin 2 receptor expression by macrophages in inflammatory bowel disease.

D. Jewell, Y. Mahida, K. Wu, 1988, Clinical and experimental immunology.

Macrophage and lymphocyte subpopulations in magnifying endoscopic lesions of Crohn's disease.

D. Jewell, P. Gionchetti, Y. Mahida, 1988, Clinical and experimental immunology.

Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis.

D. Jewell, W. Selby, G. Janossy, 1983, Journal of clinical pathology.

The genetics of NOD-like receptors in Crohn's disease.

L. Cardon, D. Jewell, G. Clarke, 2010, Tissue antigens.

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

Judy H. Cho, John P. Ferguson, G. Wainrib, 2019, Scientific Reports.

NOD2 (CARD15), the first susceptibility gene for Crohn's disease

D. Jewell, D. McGovern, D. V. van Heel, 2001, Gut.

Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project

J. González, D. Jewell, S. Vermeire, 2012, Gut.

Inhibition of binding of interferon-gamma to its receptor by salicylates used in inflammatory bowel disease.

D. Jewell, J. Aronson, B. Crotty, 1992, Gut.

Double blind, controlled trial of 4-aminosalicylic acid and prednisolone enemas in distal ulcerative colitis.

D. Jewell, I. Talbot, J. Lennard-jones, 1992, Gut.

Predicting outcome in severe ulcerative colitis.

D. Jewell, S. Travis, J. Farrant, 1996, Gut.

Strategies Finding IBD Genes

M. Parkes, J. Satsangi, D. Jewell, 1999 .

Genetics of Inflammatory Bowel Disease. A Personal View on Progress and Prospects

M. Parkes, J. Satsangi, D. Jewell, 1998, Digestive Diseases.

The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review

D. Jewell, D P Jewell, A G Fraser, 2002, Gut.

Epithelial cells bearing class II molecules stimulate allogeneic human colonic intraepithelial lymphocytes.

D. Jewell, H. Dalton, B. Crotty, 1992, Gut.

Respiratory burst capacity of human intestinal macrophage subpopulations

D. Jewell, Y. Mahida, 1990 .

Confirmation of the role of ATG16l1 as a Crohn's disease susceptibility gene

Tariq Ahmad, Carl A Anderson, Lon R Cardon, 2007, Inflammatory bowel diseases.

Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC.

Tariq Ahmad, Robert Walton, Matt Neville, 2003, Human molecular genetics.

Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease

Alastair Forbes, Carlo Berzuini, Lon Cardon, 2008, Nature Genetics.

Intestinal T-cell function.

D. Jewell, W. Selby, 1982, Gastroenterology.

cell isolation techniques . analysis by immunohistological and in inflammatory bowel disease : an Intestinal lymphocyte subpopulations

D. Jewell, W. Selby, M. Bofill, 2022 .

Long‐term results of recurrence and reoperation after strictureplasty for obstructive Crohn's disease

D. Jewell, N. McC. Mortensen, N. Mortensen, 1995 .

Ten‐year experience of strictureplasty for obstructive Crohn's disease

D. Jewell, T. Dehn, M. Kettlewell, 1989, The British journal of surgery.

Risks and benefits of azathioprine therapy

D. Jewell, D. McGovern, Dermot P.B. McGovern, 2005, Gut.

Short-chain fatty acid irrigation in severe pouchitis.

D. Jewell, H. J. de Silva, N. Mortensen, 1989, The New England journal of medicine.

Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease

D. Jewell, J. Bell, C. Julier, 1996, The Lancet.

Topical treatment of distal ulcerative colitis with 4-amino-salicylic acid enemas.

D. Jewell, W. Selby, M. Bennett, 1984, Digestion.

Cytokine gene transcription of human colonic intraepithelial lymphocytes costimulated with epithelial cells bearing HLA-DR and its inhibition by 5-aminosalicylic acid

D. Jewell, I. McGowan, Daohong Chen, 1996, Journal of Clinical Immunology.

5-Aminosalicylic acid inhibits the impaired epithelial barrier function induced by gamma interferon.

D. Jewell, B. Crotty, M. Di Paolo, 1996, Gut.

Comparison of 5-aminosalicylic acid and N-acetylaminosalicylic acid uptake by the isolated human colonic epithelial cell.

D. Jewell, J. Priddle, A. Ireland, 1992, Gut.

Mechanism of action of 5-aminosalicylic acid and its derivatives.

D. Jewell, A. Ireland, 1990, Clinical science.

Preventing postoperative recurrence of Crohn's disease

D. Jewell, N. Mortensen, N. Mortensen, 1997, The British journal of surgery.

Role of a defunctioning stoma in the management of large bowel Crohn's disease

C. M. Edwards, D. Jewell, B. Warren, 2002, The British journal of surgery.

Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres.

D. Jewell, P. Prior, R. Löfberg, 1988, Gut.

Phenotypic characterization of isolated intraepithelial lymphocytes in patients with ulcerative colitis and normal controls

D. Jewell, P. Hoang, M. Senju, 1992, Digestive Diseases and Sciences.

Two-color immunofluorescence and flow cytometric analysis of lamina propria lymphocyte subsets in ulcerative colitis and Crohn's Disease

D. Jewell, Y. Mahida, K. Wu, 1991, Digestive Diseases and Sciences.

Antigen induced suppression in peripheral blood and lamina propria mononuclear cells in inflammatory bowel disease.

D. Jewell, H. Dalton, P. Hoang, 1992, Gut.

Eresetting lymphocytes ininflammatory bowel disease. Ananalysis using monoclonal antibodies

D. Jewell, W. Selby, K. Makiyama, 1983 .

Outcome of restorative proctocolectomy with ileal reservoir for ulcerative colitis: comparison of distal colitis with more proximal disease.

D. Jewell, N. Mortensen, D. Samarasekera, 1996, Gut.

The contribution of HLA genes to IBD susceptibility and phenotype.

D. Jewell, Tariq Ahmad, L. M. Yap, 2004, Best practice & research. Clinical gastroenterology.

Fulminant Crohn’s colitis after allogeneic stem cell transplantation

D. Jewell, Tariq Ahmad, C. Verbeke, 2003, Gut.

Olsalazine in patients intolerant of sulphasalazine.

D. Jewell, A. Ireland, 1987, Scandinavian journal of gastroenterology.

Contribution of the IL‐2 and IL‐10 genes to inflammatory bowel disease (IBD) susceptibility

M. Parkes, J. Satsangi, D. Jewell, 1998, Clinical and experimental immunology.

Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship.

P. Deloukas, D. Strachan, S. Hunt, 2009, Gastroenterology.

Association of caspase-9 and RUNX3 with inflammatory bowel disease.

D. Jewell, Tariq Ahmad, S. Pathan, 2011, Tissue antigens.

A Comparison of Budesonide and Mesalamine for Active Crohn's Disease

D. Jewell, M. Vatn, F. T. Veloso, 1998 .

Slow-release 5-amino-salicylic acid (Pentasa) for the treatment of active Crohn's disease.

D. Jewell, Y. Mahida, 1990, Digestion.

The Role of Cytokines in Inflammatory Bowel Disease

D. Jewell, G. Radford-Smith, 1994, Mediators of inflammation.

Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype

L. Cardon, D. Jewell, Changcun Guo, 2007, Inflammatory bowel diseases.

Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis.

D. Jewell, R. Chapman, K. Fleming, 1988, Gut.

Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2).

D. Jewell, A. Hill, H. Rammensee, 1997, International immunology.

MECHANISMS IN NONSPECIFIC INFLAMMATORY BOWEL DISEASE

D. Jewell, R. G. Strickland, R. Strickland, 1983 .

MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease

T. Ahmad, D. Jewell, F. Seibold, 2009, Mucosal Immunology.

Pneumococcal infection in patients with coeliac disease

T. Ahmad, D. Jewell, M. Goldacre, 2008, European Journal of Gastroenterology and Hepathology.

A Method for Investigating the Effects of Drugs on the Prostaglandin Synthetase of Single Rectal Biopsies

D. Jewell, C. Hawkey, 1981 .

Immunology of inflammatory bowel disease.

D. Jewell, H. Hodgson, 1987, Bailliere's clinical gastroenterology.

IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel Disease

P. Deloukas, L. Cardon, F. Bredin, 2007, Gastroenterology.

Genetics of inflammatory bowel disease.

J. Satsangi, D. Jewell, J. Bell, 1994, The American journal of gastroenterology.

CLINICAL-ALIMENTARY TRACT IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel Disease

P. Deloukas, L. Cardon, F. Bredin, 2007 .

Clinical Implications of Inflammatory Bowel Disease Genetics on Phenotype

Fraser Cummings, D. Jewell, 2005, Inflammatory bowel diseases.

Inflammatory Bowel Disease Is Linked to 19p13 and Associated with ICAM-1

D. Jewell, M. Neville, Tariq Ahmad, 2004, Inflammatory bowel diseases.

Analysis of the IBD 5 locus and potential gene-gene interactions in Crohn ’ s disease

L. Cardon, D. Jewell, D. McGovern, 2003 .

Fine mapping of the IBD1 locus did not identify Crohn disease-associated NOD2 variants: implications for complex disease genetics.

L. Cardon, D. Jewell, D. McGovern, 2002, American journal of medical genetics.

Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3)

L. Cardon, D. Jewell, P. Scambler, 2001, European Journal of Human Genetics.

Evidence for inflammatory bowel disease of a susceptibility locus on the X chromosome.

M. Parkes, J. Satsangi, D. Jewell, 2001, Gastroenterology.

Exclusion of linkage of Crohn's disease to previously reported regions on chromosomes 12, 7, and 3 in the Belgian population indicates genetic heterogeneity.

M. Parkes, J. Satsangi, D. Jewell, 2000 .

Exclusion of Linkage of Crohn's Disease to Previously Reported Regions on Chromosomes 12, 7, and 3 in the Belgian Population Indicates Genetic Heterogeneity

M. Parkes, J. Satsangi, D. Jewell, 2000, Inflammatory bowel diseases.

Inflammatory bowel disease: progress toward a gene.

J. Satsangi, D. Jewell, D. Heel, 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3.

Y. Nakamura, M. Parkes, J. Satsangi, 1999, Human Molecular Genetics.

Ulcerative colitis and Crohn's disease—susceptibility genes and clinical patterns

D. Jewell, 1998, Journal of Gastroenterology.

Mapping susceptibility loci in inflammatory bowel disease: why and how?

M. Parkes, J. Satsangi, D. Jewell, 1997, Molecular medicine today.

The genetics of inflammatory bowel disease.

J. Satsangi, D. Jewell, J. Bell, 1997, Gut.

Clinical relevance of advances in genetics and pharmacogenetics of IBD.

T. Ahmad, D. Jewell, J. Colombel, 2004, Gastroenterology.

The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis.

T. Ahmad, D. Jewell, S. Marshall, 2003, Tissue antigens.

Genotype-phenotype analysis of the Crohn’s disease susceptibility haplotype on chromosome 5q31

D. Jewell, S. Marshall, K. Welsh, 2003, Gut.

The molecular classification of the clinical manifestations of Crohn's disease.

T. Ahmad, D. Jewell, M. Barnardo, 2002, Gastroenterology.

Genetic markers may predict disease behavior in patients with ulcerative colitis.

J. Satsangi, D. Jewell, S. Targan, 1997, Gastroenterology.

Crypt cell proliferation and HLA-DR expression in pelvic ileal pouches.

D. Jewell, K. Gatter, P. Millard, 1990, Journal of clinical pathology.

Ulcerative enteritis.

D. Jewell, 1983, British medical journal.

Outcome of 200 restorative proctocolectomy operations: The John Radcliffe Hospital experience

D. Jewell, N. McC. Mortensen, D. Samarasekera, 1997, The British journal of surgery.

Genotype‐based phenotyping heralds a new taxonomy for inflammatory bowel disease

T. Ahmad, D. Jewell, S. Marshall, 2003, Current opinion in gastroenterology.

Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors.

L. Cardon, D. Kwiatkowski, D. Jewell, 2002 .

Contribution of the MHC region to the familial risk of coeliac disease

D. Jewell, R. Houlston, G. Holmes, 1999, Journal of medical genetics.

Intestinal permeability in the ileal pouch.

D. Jewell, N. Mortensen, N. Soper, 1996, Gut.

Lactulose hydrogen breath test in the diagnosis of bacterial overgrowth.

D. Jewell, J. Rhodes, 1990, Gastroenterology.

Contribution of histological, serological, and genetic factors to the clinical heterogeneity of adult-onset coeliac disease

D. Jewell, B. Warren, M. Barnardo, 2009, Scandinavian journal of gastroenterology.

The IL-23/IL-17 pathway in inflammatory bowel disease

D. Jewell, A. Geremia, 2012, Expert review of gastroenterology & hepatology.

Indeterminate colitis: A review of the concept — What's in a name?

D. Jewell, M. Vatn, B. Warren, 2008, Inflammatory bowel diseases.

Genetics of inflammatory bowel disease: the role of the HLA complex.

T. Ahmad, D. Jewell, S. Marshall, 2006, World journal of gastroenterology.

HIV associated cytomegalovirus colitis as a mimic of inflammatory bowel disease.

D. Jewell, D. Roskell, A. Campbell, 1995, Gut.

Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.

D. Jewell, R. Chapman, K. Fleming, 1989, Clinical and experimental immunology.

Immune complexes in ulcerative colitis and Crohn's disease.

D. Jewell, H. Hodgson, B. Potter, 1977, Clinical and experimental immunology.

Immune Complexes in Inflammatory Bowel Disease

D. Jewell, H. Hodgson, B. Potter, 1976 .

Azathioprine in Ulcerative Colitis: An Interim Report on a Controlled Therapeutic Trial

D. Jewell, S. Truelove, 1972, British medical journal.

Recurrence After Abdominal Surgery for Crohn’s Disease

D. Jewell, B. Warren, B. George, 2002, Diseases of the colon and rectum.

A common CTLA4 haplotype associated with coeliac disease

D. Jewell, D. McGovern, D. Heel, 2005, European Journal of Human Genetics.

Recurrence and reoperation after strictureplasty for obstructive Crohn's disease: long-term results [corrected].

D. Jewell, N. Mortensen, M. Kettlewell, 1995, The British journal of surgery.

Medical therapy for induction and maintenance of remission in pouchitis: a systematic review.

D. Jewell, R. McLeod, W. Sandborn, 1999, Inflammatory bowel diseases.

Meta‐analysis using individual patient data: efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitis

D. Jewell, S. Vegter, K. Tolley, 2013, Alimentary pharmacology & therapeutics.

Crohn's disease and pregnancy.

D. Jewell, C. P. Willoughby, R. Khosla, 1984, Gut.

Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms?

T. Ahmad, D. Jewell, S. Marshall, 2003, Arthritis and rheumatism.

Genome screening of coeliac disease

D. Jewell, G. Holmes, P. Howdle, 2002, Journal of medical genetics.

Variation in the CTLA4/CD28 gene region confers an increased risk of coeliac disease

D. Jewell, G. Holmes, J. Walters, 2002 .

Linkage analysis of candidate regions for coeliac disease genes.

D. Jewell, S. Seal, R. Houlston, 1997, Human molecular genetics.

ALTERED EXPRESSION OF TGFα AND TGFβ1 IN THE MUCOSA OF THE FUNCTIONING PELVIC ILEAL POUCH

D. Jewell, C. Lewis, J. McGee, 1996 .

Long-Term Function After Restorative Proctocolectomy

D. Jewell, N. Mortensen, J. Wheeler, 2005, Diseases of the colon and rectum.

Primary sclerosing cholangitis--an immunologically mediated disease?

D. Jewell, R. Chapman, 1985, The Western journal of medicine.

Class IIantigen (HLA-DR)expression byintestinal epithelial cells ininflammatory diseases ofcolon

D. Jewell, G. McDonald, 1987 .

Medical Therapy for Induction and Maintenance of Remission in Pouchitis: A Systematic Review

D. Jewell, R. McLeod, W. Sandborn, 1999 .

Effect of heparin on polymerase chain reaction

J. I. Bell, M. Bunce, J. Satsangi, 1994, The Lancet.

Pulmonary function in inflammatory bowel disease.

D. Jewell, A. Mee, S. W. Clarke, 1978, Digestion.

Susceptibility loci in inflammatory bowel disease

M. Parkes, J. Satsangi, D. Jewell, 1996, The Lancet.

Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers.

D. Jewell, S. Vermeire, Jenny C. Taylor, 2011, Journal of Crohn's & colitis.

The Immunology of Ulcerative Colitis and Crohn’s Disease

D. Jewell, 1979 .

Association between genetic variants in myosin IXB and Crohn's disease

Fraser Cummings, D. Jewell, Changcun Guo, 2009, Inflammatory bowel diseases.

Clinical and molecular characteristics of isolated colonic Crohn's disease

Fraser Cummings, D. Jewell, B. Warren, 2008, Inflammatory bowel diseases.

Two‐stage candidate gene study of chromosome 3p demonstrates an association between nonsynonymous variants in the MST1R gene and Crohn's disease

Fraser Cummings, D. Jewell, Changcun Guo, 2008, Inflammatory bowel diseases.

Atopy in inflammatory bowel disease.

D. Jewell, A. Mee, D. Brown, 1979, Scandinavian journal of gastroenterology.

Crohn's disease andpregnancy.

D. Jewell, C. P. Willoughby, R. Khosla, 2011 .

Cap polyposis : an inflammatory disorder or a spectrum of mucosal prolapse syndrome ?

D. Jewell, R. Playford, D. V. van Heel, 2005 .

CARD15 polymorphisms in Behçet's disease

T. Ahmad, D. Jewell, S. Marshall, 2005, Scandinavian Journal of Rheumatology.

Articular and ocular complications of inflammatory bowel disease

D. Jewell, T. Orchard, 2003 .

Sacroiliac joint uptake ratios in inflammatory bowel disease: relationship to back pain and to activity of bowel disease.

D. Jewell, J. Agnew, D. G. Pocock, 1982, The British journal of radiology.

The pharmacogenetics of methotrexate in inflammatory bowel disease

D. Jewell, M. Barnardo, M. Schwab, 2005 .

The prevalence, clinical features and association of HLA‐B27 in sacroiliitis associated with established Crohn’s disease

D. Jewell, E. Mcnally, Bryan Paul Wordsworth, 2009, Alimentary pharmacology & therapeutics.

Genetics of inflammatory bowel disease: why is it important?

D. Jewell, 2000 .

Spirochaetosis of the human rectum associated with an intraepithelial mast cell and IgE plasma cell response.

D. Jewell, J. Gebbers, P. Kelly, 1987, Gut.

[Local immune reaction in human intestinal spirochetosis].

D. Jewell, J. Gebbers, D. Ferguson, 1987, Schweizerische medizinische Wochenschrift.

OUTPATIENT PREPARATION FOR COLONOSCOPY

D. Jewell, J. Brown, 1981, The Lancet.

Histological features of sclerosing cholangitis in patients with chronic ulcerative colitis.

D. Jewell, R. Chapman, C. Barbatis, 1985, Journal of clinical pathology.

TUCAN (CARD8) genetic variants and inflammatory bowel disease.

J. Ragoussis, L. Cardon, D. Jewell, 2006, Gastroenterology.

Immunoglobulin production by isolated intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease.

D. Jewell, J. Priddle, Y. Mahida, 1989, Clinical and experimental immunology.

Human colonic intraepithelial lymphocytes suppress in vitro immunoglobulin synthesis by autologous peripheral blood lymphocytes and lamina propria lymphocytes.

D. Jewell, H. Dalton, B. Crotty, 1993, Gut.

Lack of association of MYO9B genetic variants with coeliac disease in a British cohort

D. Strachan, C. Wijmenga, W. McArdle, 2006, Gut.

Infl iximab versus ciclosporin in severe ulcerative colitis

D. Jewell, 2012 .

The management of acute severe ulcerative colitis.

D. Jewell, H. Dalton, 1991, Annals of medicine.

In vitro model for the assessment of luminal factors on rectal mucosa.

D. Jewell, A. Allan, 1983, Gut.

Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis.

D. Jewell, J. Rhodes, B. Potter, 1982, Gastroenterology.

The humoral immune system in inflammatory bowel disease

D. Jewell, H. Hodgson, 1978, The American journal of digestive diseases.

Treatment of Crohn's disease--the new era.

D. Jewell, 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Infliximab for ulcerative colitis.

D. Jewell, J. Simmons, 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Genotype-phenotype analysis of the Crohn’s disease susceptibility haplotype on chromosome 5q31

D. Jewell, S. Marshall, K. Welsh, 2003 .

Side effects of azathioprine treatment given for inflammatory bowel disease-a 30 year audit

D. Jewell, A. Fraser, 2000 .

DISODIUM AZODISALICYLATE IN ULCERATIVE COLITIS

D. Jewell, S. Truelove, 1981, The Lancet.

C3 metabolism in ulcerative colitis and Crohn's disease.

D. Jewell, H. Hodgson, B. Potter, 1977, Clinical and experimental immunology.

Glycosylation and sulphation of colonic mucus glycoproteins in patients with ulcerative colitis and in healthy subjects.

P. W. Kent, D. Jewell, H. Morita, 1993, Gut.

Effects of olsalazine in the j ej unum of the rat

D. Jewell, J. Priddle, D. S. Parsons, 2006 .

Effects of olsalazine in the jejunum of the rat.

D. Jewell, J. Priddle, D. S. Parsons, 1987, Gut.

Ulcerative colitis

D. Jewell, 1992, Frontiers of gastrointestinal research.

Acute inflammation in ideal pouches(pouchitis)

D. Jewell, N. Mortensen, H. J. Silva, 1991 .

A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis.

J. Satsangi, D. Jewell, R. Chapman, 2001, Gastroenterology.

MONOCYTE ACID HYDROLASES IN INFLAMMATORY BOWEL DISEASE

D. Jewell, A. Mee, 1978, The Lancet.

Pigbel-like syndrome in a vegetarian in Oxford.

D. Jewell, Z. Traill, J. Farrant, 1996, Gut.

Cap polyposis--an unusual cause of diarrhoea.

D. Jewell, R. Chapman, M. Kettlewell, 1993, Gut.

Selective IgA deficiency and Crohn's disease: report of two cases.

D. Jewell, H. Hodgson, 1977, Gut.

Carbenoxolone (duogastrone) and cimetidine in the treatment of duodenal ulcer--a therapeutic trial.

P. I. Reed, D. Jewell, P. Cook, 1980, Scandinavian journal of gastroenterology. Supplement.

Factors affecting the spontaneous cell-mediated cytotoxicity of intestinal mononuclear cells.

D. Jewell, P. Gibson, A. Hermanowicz, 1984, Immunology.

Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis.

D. Jewell, R. Chapman, K. Fleming, 1989, Journal of hepatology.

Yersinia colitis associated with Crohn's disease.

D. Jewell, D. Treacher, 1985, Postgraduate medical journal.

W1223 Genetic Factors Conferring an Increased Susceptibility to Develop Crohn's Disease Also Influence Disease Phenotype, but Do Not Predict it. Results From the IBDChip European Project

J. González, D. Jewell, S. Vermeire, 2010 .

Ulcerative colitis and sarcoidosis.

D. Jewell, D. Shale, G. Barr, 1986, Postgraduate medical journal.

Clinical Trials ñ Past, Present and Future

D. Jewell, 2002 .

Proceedings: Etiology of ulcerative colitis.

D. Jewell, 1973, Proceedings of the Royal Society of Medicine.

Topics in Gastroenterology

D. Jewell, S. Truelove, M. Heyworth, 1981 .

Proceedings: Complement in inflammatory bowel disease.

D. Jewell, H. Hodgson, B. Potter, 1975, Gut.

Association of small intestinal diverticulosis with chronic pancreatitis leading to severe malabsorption. Report of three cases.

D. Jewell, R. Chapman, Y. Mahida, 1988, Postgraduate medical journal.

Two-Stage Genome-Wide Search in Inflammatory Bowel Disease: Strong Evidence for Susceptibility LOCI on Chromosomes 3, 7 and 12

M. Parkes, J. Satsangi, D. Jewell, 1997 .

Fibrolamellar hepatocellular carcinoma complicating ulcerative colitis with primary sclerosing cholangitis.

D. Jewell, R. Chapman, J. Snook, 1989, Gut.

Cimetidine and cerebral blood flow in elderly patients.

D. Jewell, P. Cook, I. James, 1981, British journal of clinical pharmacology.

Comparative study of carbenoxolone and cimetidine in the management of duodenal ulcer.

J. H. Baron, P. I. Reed, D. Jewell, 1983, Acta gastro-enterologica Belgica.

The pharmacogenetics of methotrexate in inflammatory bowel disease.

T. Ahmad, D. Jewell, M. Barnardo, 2005, Pharmacogenetics & Genomics.

Colonic bacterial proteases to IgA1 and sIgA in patients with ulcerative colitis.

D. Jewell, J. Priddle, M. J. Hudson, 1987, Gut.

colitis . and sIgA in patients with ulcerative Colonic bacterial proteases to IgA 1

D. Jewell, J. Priddle, M. J. Hudson, 2006 .

A study of patients with alcoholic liver disease by 31P nuclear magnetic resonance spectroscopy.

G K Radda, D. Jewell, G. Radda, 1990, Clinical science.

Precision mapping of chromosome 12 linkage in IBD: Evidence for a haplotype association

M. Parkes, J. Satsangi, D. Jewell, 1998 .

Comparison between Prospective and Retrospective Evaluation of Crohn's Disease Activity Index

D. Jewell, S. Travis, L. Camporota, 2003, The American Journal of Gastroenterology.

Immunoregulatory mechanisms in nonspecific inflammatory bowel disease.

D. Jewell, R. G. Strickland, R. Strickland, 1983, Annual review of medicine.

Site of action of platelet-activating factor within the mucosa of rabbit distal colon.

D. Jewell, S. Travis, B. Crotty, 1995, Clinical science.

Long‐term risk of malignancy after treatment of inflammatory bowel disease with azathioprine

D. Jewell, T. Orchard, D. Jewell, 2002, Alimentary pharmacology & therapeutics.

Randomized, double‐blind, placebo‐controlled trial of oral aloe vera gel for active ulcerative colitis

D. Jewell, D. Rampton, L. Langmead, 2004, Alimentary pharmacology & therapeutics.

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants.

P. Donnelly, C. Spencer, A. Silman, 2007, Nature genetics.

Ulcerative colitis and Crohn's disease: molecular genetics and clinical implications

M. Parkes, D. Jewell, D. Jewell, 2001, Expert Reviews in Molecular Medicine.

Inflammatory bowel disease is associated with a functional TNF polymorphism that affects an OCT1/NF-KB transcription factor interaction

L. Cardon, D. Kwiatkowski, D. Jewell, 2002 .

Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A

Simon C. Potter, C. Spencer, A. Silman, 2007, Nature.

Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region

Simon C. Potter, P. Donnelly, C. Spencer, 2009, Nature Genetics.

Genetics of inflammatory bowel disease.

M. Parkes, J. Satsangi, D. Jewell, 1998, Clinical science.

Perianal Crohn's disease

D. Jewell, N. McC. Mortensen, B. George, 2004, The British journal of surgery.

The Immunology of Celiac Disease

D. Jewell, G. Mantzaris, W. Rosenberg, 1992 .

MHC class I chain‐like gene A (MICA) and its associations with inflammatory bowel disease and peripheral arthropathy

D. Jewell, R. Vaughan, K. Welsh, 2001, Clinical and experimental immunology.

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

Lisa, Husam, John P. Ferguson, 2023 .

Cytokine (TNFα, LTα and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies

J. Satsangi, D. Jewell, K. Welsh, 2000, Genes and Immunity.

Conditions of the Eyes and Joints Associated with Inflammatory Bowel Disease

D. Jewell, T. Orchard, 2010 .

T1243 NOD2 Activation By Muramyl Dipeptide Induces Autophagy in Dendritic Cells in An ATG16l1 Dependent Pathway

D. Jewell, A. Simmons, R. Cooney, 2008 .

Do HLA antigens predict the occurrence of extraintestinal manifestations of IBD?

D. Jewell, 2008, Inflammatory bowel diseases.

Clinical patterns of familial inflammatory bowel disease.

J. Satsangi, D. Jewell, D. Jewell, 1996, Gut.

The management of severe Crohn’s disease

M. Parkes, D. Jewell, D. Jewell, 2001, Alimentary pharmacology & therapeutics.

Genotype-phenotype analysis of the Crohn’s disease susceptibility haplotype on chromosome 5q31

D. Jewell, S. Gruber, J. Struewing, 2003, Gut.

Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1.

D. Jewell, R. Chapman, Xuesong Yang, 2004, Journal of hepatology.

I.O.I.B.D. Questionnaire on the clinical use of Azathioprine, 6-Mercaptopurine, Cyclosporine-A and Methotrexate in the treatment of I.B.D

D. Jewell, J. Rask-Madsen, K. Ewe, 1996 .

Interleukin-23R arg381 gln is associated with susceptibility to Crohn's disease but not with phenotype in an Italian population - Reply

M. Tremelling, M. Parkes, C. Lees, 2007 .

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

P. Donnelly, C. Spencer, A. Silman, 2007, Nature Genetics.

Colitis: Diagnosis and Therapeutic Strategies

D. Jewell, B. Warren, J. Colombel, 2006 .

60 P The 5q31/IBD5 risk haplotype is associated with overall susceptibility to Crohn's disease and determines perianal phenotype

D. Jewell, D. Heel, Tariq Ahmad, 2002 .

The genetics of inflammatory bowel disease

J. Satsangi, D. Jewell, M. Bunce, 2001, Alimentary pharmacology & therapeutics.

Clinical Dilemmas in Inflammatory Bowel Disease

D. Jewell, 2007, Gut.

Response to faecal challenge in defunctioned colonic Crohn's disease: prediction of long‐term course

D. Jewell, N. Mortensen, R. Fasoli, 1990, The British journal of surgery.

The Genetic Basis of Inflammatory Bowel Disease

D. Jewell, R. Cooney, 2009, Digestive Diseases.

Microscopic Colitis: a Clinical and Pathological Review

D. Jewell, B. Warren, D. Jewell, 2002, Scandinavian journal of gastroenterology.

Cytokine Production by Human Colonic Intraepithelial Lymphocytes in Controls and Ulcerative Colitis

D. Jewell, H. Dalton, P. Hoang, 1994, Mediators of inflammation.

Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors.

L. Cardon, D. Kwiatkowski, D. Jewell, 2002, Human molecular genetics.

Macrophage andlymphocyte subpopulations inmagnifying endoscopic lesions ofCrohn's disease

D. Jewell, P. Gionchetti, Y. Mahida, 1988 .

The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link

D. Jewell, B. Warren, N. Mortensen, 2000, The Journal of pathology.

Primary antibody deficiency and Crohn's disease

D. Jewell, N. Snowden, J. Shaffer, 1999, Postgraduate medical journal.

Pneumococcal infection in patients with coeliac disease

T. Ahmad, D. Jewell, M. Goldacre, 2008, European journal of gastroenterology & hepatology.

Outcome of 200 restorative proctocolectomy operations: The John Radcliffe Hospital experience

D. Jewell, D. Samarasekera, M. Kettlewell, 1997, The British journal of surgery.

Ileoanal reservoir dysfunction: A problem‐solving approach

D. Jewell, M. Thompson-Fawcett, N. Mortensen, 1997, The British journal of surgery.

Immunoglobulin production byisolated intestinal mononuclear cells frompatients withulcerative colitis andCrohn's disease

D. Jewell, J. Priddle, Y. Mahida, 1989 .

Selective IgA deficiency and Crohn's disease: report of two cases.

D. Jewell, H. Hodgson, 1977, Gut.

Smoking benefits celiac sprue and pouchitis: implications for nicotine therapy?

D. Jewell, C. Lee-Elliott, D. Nicholas, 1997, Gastroenterology.